Shares of National Health Investors, Inc. (NYSE:NHI - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven brokerages that are presently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $73.29.
NHI has been the topic of a number of recent analyst reports. Wells Fargo & Company downgraded shares of National Health Investors from an "overweight" rating to an "equal weight" rating and boosted their target price for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Bank of America started coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 target price on the stock. Truist Financial raised their target price on shares of National Health Investors from $65.00 to $78.00 and gave the company a "hold" rating in a research note on Friday, August 30th. Finally, StockNews.com downgraded National Health Investors from a "buy" rating to a "hold" rating in a research report on Tuesday, October 15th.
Read Our Latest Analysis on National Health Investors
National Health Investors Trading Down 0.7 %
NYSE:NHI traded down $0.58 on Monday, reaching $77.16. The company's stock had a trading volume of 122,239 shares, compared to its average volume of 197,097. National Health Investors has a 1-year low of $51.59 and a 1-year high of $86.13. The business's 50-day moving average price is $79.97 and its two-hundred day moving average price is $74.14. The firm has a market cap of $3.50 billion, a PE ratio of 26.52, a PEG ratio of 5.19 and a beta of 1.05. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29.
National Health Investors (NYSE:NHI - Get Free Report) last announced its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The company had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. During the same period in the previous year, the company posted $1.08 earnings per share. National Health Investors's revenue for the quarter was up 1.7% on a year-over-year basis. Equities research analysts anticipate that National Health Investors will post 4.42 earnings per share for the current fiscal year.
National Health Investors Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.67%. The ex-dividend date is Tuesday, December 31st. National Health Investors's dividend payout ratio (DPR) is presently 123.71%.
Hedge Funds Weigh In On National Health Investors
A number of institutional investors and hedge funds have recently made changes to their positions in NHI. Quarry LP acquired a new position in National Health Investors during the third quarter worth $27,000. Strategic Financial Concepts LLC acquired a new stake in shares of National Health Investors in the 2nd quarter worth about $28,000. Covestor Ltd lifted its position in National Health Investors by 2,700.0% in the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust's stock valued at $35,000 after acquiring an additional 405 shares in the last quarter. Point72 DIFC Ltd acquired a new position in National Health Investors during the 3rd quarter valued at about $35,000. Finally, International Assets Investment Management LLC acquired a new position in National Health Investors during the 2nd quarter valued at about $36,000. Institutional investors own 62.51% of the company's stock.
About National Health Investors
(
Get Free ReportIncorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
